Quick Answer
Minerva Neurosciences, Inc. reported Research And Development Expense of $5.76 million for the year ending 2025.
- Minerva Neurosciences, Inc. showed a decrease of -51.6% in Research And Development Expense from 2024 to 2025.
- This data is from Minerva Neurosciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 11, 2026.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 13 years of available data (2013 to 2025), Minerva Neurosciences, Inc.'s Research And Development Expense has grown by 712.9%.
- Historical annual values: Fiscal year 2025: $5.76 million | Fiscal year 2024: $11.90 million | Fiscal year 2023: $12.71 million | Fiscal year 2022: $14.65 million | Fiscal year 2021: $32.04 million | Fiscal year 2020: $22.04 million | Fiscal year 2019: $58.12 million | Fiscal year 2018: $34.89 million | Fiscal year 2017: $30.26 million | Fiscal year 2016: $20.44 million | Fiscal year 2015: $18.53 million | Fiscal year 2014: $42.91 million | Fiscal year 2013: $708.5 thousand.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: